GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lombard Medical Technologies PLC (LSE:LMT) » Definitions » Debt-to-Revenue

Lombard Medical Technologies (LSE:LMT) Debt-to-Revenue : 0.71 (As of Dec. 2012)


View and export this data going back to . Start your Free Trial

What is Lombard Medical Technologies Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Lombard Medical Technologies's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2012 was £2.76 Mil. Lombard Medical Technologies's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2012 was £0.00 Mil. Lombard Medical Technologies's annualized Revenue for the quarter that ended in Dec. 2012 was £3.89 Mil. Lombard Medical Technologies's annualized Debt-to-Revenue for the quarter that ended in Dec. 2012 was 0.71.


Lombard Medical Technologies Debt-to-Revenue Historical Data

The historical data trend for Lombard Medical Technologies's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lombard Medical Technologies Debt-to-Revenue Chart

Lombard Medical Technologies Annual Data
Trend Sep02 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.73 - - - 0.71

Lombard Medical Technologies Semi-Annual Data
Sep02 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.73 - - - 0.71

Competitive Comparison of Lombard Medical Technologies's Debt-to-Revenue

For the Medical Instruments & Supplies subindustry, Lombard Medical Technologies's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lombard Medical Technologies's Debt-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lombard Medical Technologies's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Lombard Medical Technologies's Debt-to-Revenue falls into.



Lombard Medical Technologies Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Lombard Medical Technologies's Debt-to-Revenue for the fiscal year that ended in Dec. 2012 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(2.762 + 0) / 3.89
=0.71

Lombard Medical Technologies's annualized Debt-to-Revenue for the quarter that ended in Dec. 2012 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(2.762 + 0) / 3.89
=0.71

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is one times the quarterly (Dec. 2012) Revenue data.


Lombard Medical Technologies Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Lombard Medical Technologies's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Lombard Medical Technologies (LSE:LMT) Business Description

Traded in Other Exchanges
N/A
Address
Lombard Medical Technologies PLC is engaged in the design and development of endovascular stent grafts, their manufacture, and commercialization either directly through the group's own sales force or through a network of local distributors supported by clinical specialists from Lombard Medical. The principal product, the AorfixT AAA stent graft has European CE mark approval for use in patients with high-angle-neck aneurysms of up to 90 degrees. The group has operations in United Kingdom and United States of America.